demonstrated an enzyme system in vertebrate kidney that converts 25-hydroxycholecalciferol into its most active metabolite, 1,25-dihydroxycholecalciferol. Both whole-tissue homogenates and a particulate fraction (characterized as 'large' mitochondria) have been shown to carry out the reaction (Fraser & Kodicek, 1970; Gray et al., 1972) , which is inhibited by Ca2+ (Galante et ul., 1972b; Fraser & Kodicek, 1973) .
We have now extended our preliminary studies of inhibition by Ca2+, and have also shown that a cytoplasmic factor or factors markedly enhances the reaction in homogenates ofchick kidney. One ofthese factors may be identical with a substance, located in the cytoplasm of this tissue, that binds 25-hydroxycholecalciferol. Its presence may account for some of the differences that have been observed between particulate preparations and whole-tissue homogenates in the substrate concentrations required to support the reaction.
Experimental
Preparation of kidney homogenates. One-day-old white Leghorn chicks were fed on a vitamin Ddeficient diet (calcium 0.34 %, phosphorus 0.54 %) for [3] [4] weeks. The chicks were killed by decapitation and the kidney tissue was removed immediately and placed on ice. Homogenates (2 %, w/v) were prepared, in a Potter-Elvehjem homogenizer, in ice-cold 15 mmTris -acetate buffer, pH 7.4, supplemented with MgCI2 (1.9mM), sodium succinate (5mM) and sucrose (200mM) .
Assay of 25-hydroxycholecalciferol 1-hydroxylase activity. Portions (3ml) of homogenates were preincubated at 37°C for 5min, and the substrate 25-hydroxycholecalciferol (25-hydroxy[26(27) Bligh & Dyer (1959) . The extracts were chromatographed on columns (20cm x 1.5cm) containing 8.5g of Sephadex (Pharmacia AB, Uppsala, Sweden). The metabolites were eluted with chloroform-n-hexane (13:7, v/v) and the eluates were collected directly into scintillation-counter vials. The radioactivity corresponding to each metabolite was measured by liquid-scintillation counting at constant efficiency (Holick & DeLuca, 1971; Galante et al., 1972a) . Under the assay conditions described above, production of 1,25-dihydroxycholecalciferol was linear with time up to 20min, falling off rapidly beyond this until at 80min no further increase in the production was observed. The production of 1,25-dihydroxycholecalciferol was proportional to the homogenate concentration in the range 2-10 % (w/v), and no enzyme activity was observed with homogenates that had previously been boiled for 20min. Formation of the dihydroxy metabolite was maximum between pH7.0 and 7.5.
In Haddad & Chyu (1971) . In order to study the hydroxylase activities of particulate and cytoplasmic fractions, a 4% (w/v) homogenate of kidney tissue was prepared in 15mm-Tris -acetate buffer, pH7.4, supplemented with MgCl2 (1.9mM), sodium succinate (5mM), sucrose (200mM), glucose 6-phosphate (5mM), NADP+ (0.33mM) and glucose 6-phosphate dehydrogenase (600 units/i). The homogenate was centrifuged at 105000ga, for 60min. The supernatant was retained and the sediment was washed twice by resuspension in fresh medium and re-centrifugation. The rates of 1-hydroxylation of 25-hydroxycholecalciferol catalysed by the supernatant and particulate fractions separately, and by a reconstituted preparation made by resuspending the washed sediment in supernatant, were compared with that of the original homogenate.
Results and discussion
Increasing the concentration of Ca2+ in the assay medium produced a pronounced inhibition of 1-hydroxylation, which was virtually complete at 0.5mM-Ca2+ with a substrate concentration of 5nM (Fig. 1) . Addition of the chelating agent EGTA enhanced the formation of 1,25-dihydroxycholecalciferol so that the maximum rate of production was obtained at a final concentration of EGTA of 0.2mM. The ability of low concentrations of EGTA to enhance hydroxylase activity is probably due to removal of free Ca2+ present in the homogenate. If this is the case, zero Ca2+ concentration would correspond to 0.2mM-EGTA, the point at which the maximum rate of hydroxylation was observed. Since 1 mol of EGTA combines with 2mol of Ca2+, the maximum effect of Ca2+ on the rate of production of the dihydroxy metabolite appears to occur over a concentration range of these ions of approx. 0-0.5mM. A decline in the rate of 1-hydroxylation was observed at EGTA concentrations greater than 0.2mM: this may represent the effect of chelation of metal ions other than Ca2+ that are essential to enzyme activity, e.g. Mg2+ (Fraser & Kodicek, 1970; Gray et aL, 1972) .
In the absence ofadded Ca2+, addition ofincreasing amounts of Pi, up to a final concentration of 20mM, had no effect on the rate of hydroxylation. However, when Ca2+ was present in an inhibitory concentration (0.2mM), Pi at concentrations above 8mM reversed this effect so that, in the presence of 20mM-Pi and 0.2mM-Ca2+, a rate approaching that attained with no added Ca2+ was observed. Pi thus appears to prevent inhibition by Ca2+, perhaps by lowering the effective Ca2+ concentration.
An apparent Km of 1 x 10-7M was calculated from the linear regression of the reciprocal of the rate of 1-hydroxylation on the reciprocal of the concentration ofadded 25-hydroxycholecalciferol, over the substrate concentration range 1-560nM. This value for Km is significantly lower than that of 2.2x 10-6M reported by Gray et al. (1972) for the 1-hydroxylation reaction catalysed by isolated mitochondria. A possible explanation is that the Km observed in homogenates does not correspond to the uptake offree substrate by the mitochondrial hydroxylase but to an earlier stage in the overall reaction. Proteins with the ability to bind metabolites ofcholecalciferol have been identified in several vertebrate tissues and plasma (Edelstein et al., 1972) , and one such, present in the cytoplasm of rat kidney, has been used by Haddad & Chyu (1971) as the basis of an assay of 25-hydroxycholecalciferol. The possibility that a protein able to bind 25-hydroxycholecalciferol might occur in chick kidney homogenates was investigated, and the presence of a specific factor capable of binding 25-hydroxycholecalciferol, without catalysing its conversion into 1,25-dihydroxycholecalciferol, was de- Final curve was obtained for the plot of percentage radioactivity bound versus concentration of unlabelled substrate (Fig. 2) , and a linear plot of the data indicated an association constant of approx. 3 x 10-9M. More direct evidence for the participation of a cytoplasmic factor in the hydroxylation reaction was obtained from experiments on the separated and recombined particulate and cytoplasmic fractions.
When portions of the separated fractions and reconstituted preparations (equivalent in amounts to the original homogenate) were used, the rates of reaction (averages of four experiments) were respectively 3.6 % (particulate fraction), zero (soluble fraction) and 29.5 % (recombined preparation) of the rate with unfractionated homogenate. The substrate concentration was 125nM.
It is possible that some cytoplasmic factor other than that which binds 25-hydroxycholecalciferol may be responsible for the enhanced rate of 1-hydroxylation observed with the reconstituted preparation. However, the incubation medium used was shown in a separate experiment to be capable of supporting Vol. 134 hydroxylation by much higher concentrations [equivalent to a 50% (w/v) homogenate] of a particulate fraction.
If the properties of the 25-hydroxycholecalciferol 1-hydroxylase system of chick kidney homogenates are shared by the intact system in vivo, the results of our experiments suggest two possible physiological mechanisms for the control of cholecalciferol metabolism. The first is the regulation of the hydroxylase activity by the intracellular concentration of Ca2 , such that the rate of hydroxylation responds instantaneously and inversely to changes in the concentration of this ion. Intracellular Ca2+ concentration is in turn influenced by parathyroid hormone (Parsons & Robinson, 1971) and possibly by calcitonin (Parkinson & Radde, 1969) . The maximum effect of Ca2+ on the rate of 1-hydroxylation is seen with this ion over the concentration range 0-0.5mM. The upper limit of this range is higher than the accepted range for the cytoplasmic concentration of Ca2+ of 0.1 uM (Rasmussen, 1970) . However, the site of the inhibitory action of Ca2+ on the hydroxylase system is not yet known, and inhibition may take place in an intracellular region, such as mitochondria, with a higher Ca2+ concentration than that of the whole cell. Fraser & Kodicek (1973) have concluded that direct control of 25-hydroxycholecalciferol 1-hydroxylase activity by Ca2+ is unlikely, since they failed to demonstrate a decrease in hydroxylation in kidney homogenates from vitamin D-deficient chicks after restoration of the serum calcium concentration to normal by the administration of cholecalciferol. However, this conclusion assumes that the serum calcium concentration accurately reflects the intracellular Ca2+ concentration.
The second potential regulatory factor, and one perhaps more suited to longer-term adaptation to altered metabolic needs, is the concentration of the presumed 25-hydroxycholecalciferol-binding protein in the cytoplasm. Fraser & Kodicek (1970) and Gray et al. (1972) have shown that the 1-hydroxylase system present in isolated mitochondria is able to form 1 ,25-dihydroxycholecalciferol from free 25-hydroxycholecalciferol, but that the Km for this reaction is about 2 x 10-6M (Gray et al., 1972) . If it is assumed that the Km of the enzyme reflects its affinity for substrate, the affinity of the cytoplasmic binding protein for 25-hydroxycholecalciferol is 1000-fold greater than that of the hydroxylase. In the intact cell the 25-hydroxycholecalciferol 1-hydroxylase is believed to be located in mitochondria and 25-hydroxycholecalciferol reaches the cell from its site of production in the liver by way of the circulation. The effect of the binding protein may therefore be to accumulate 25-hydroxycholecalciferol, raising its concentration in the region of the enzyme and thus increasing the rate of product formation at concentrations that would be well below the Km if the free substrate were uniformly distributed throughout the intra-and extra-cellular fluids. For this hypothesis to be valid, either the protein-bound form of 25-hydroxycholecalciferol must be a substrate of the enzyme or some change that diminishes the affinity of the protein for 25-hydroxycholecalciferol in the vicinity of the enzyme must take place, since without some process of this nature it is difficult to see how the enzyme could compete successfully with the binding protein for the free substrate. If on the other hand the enzyme and binding protein act independently on free 25-hydroxycholecalciferol in homogenates, curved (convex-upwards) double-reciprocal plots of 1/v against 1/s should be observed, but such curvature was not detected in our experiments.
